Loading chat...
NJ S2024
Bill
Status
Passed
12/5/2016
Primary Sponsor
Fred Madden
Click for details
AI Summary
Legislative Description
Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
Bills and Joint Resolutions Signed by the Governor
Last Action
Approved P.L.2016, c.73.
12/5/2016
Committee Referrals
Health and Senior Services6/30/2016
Health, Human Services and Senior Citizens4/18/2016
Full Bill Text
No bill text available